International Thymic Malignancy Interest Group is ranked among medical research organizations in Sleepy Hollow, NY, with an America's Best Score of 61 out of 100, based on its 2025 Form 990.
International Thymic Malignancy Interest Group is a 501(c)(3) organization, classified under Medical Research (NTEE H19). Contributions are tax-deductible.
102 Legend Drive, Sleepy Hollow, NY 10591-3400
In fiscal year 2025 it reported $216,569 in revenue and $313,492 in expenses, with contributions making up 100.0% of revenue.
The mission of ITMIG is to promote the advancement of clinical and basic science pertaining to thymic and other mediastinal malignancies and related conditions ITMIG is a multidisciplinary group currently consisting of surgeons, pathologists, imaging specialists, oncologists, and neurologists, aiming for better management of patients with thymic tumors through an optimized interaction between the disciplines. The academic journal Mediastinum has become the official journal of the International Thymic Malignancy Interest Group! This represents a collaborative partnership between two institutions. The ITMIG database is a major resource for studying the characteristics, treatment strategies, and outcomes of patients with thymic malignancies, has reopened More than 2000 patients are enrolled.
Largest programs · fiscal year 2025
ITMIG is aligned with the Foundation for Thymic Cancer Research to advance program services through coordination of the executive director. The executive director is responsible for all activities related to the organization and all program services.$183,000 spent · 71.9% of program spending
Research and related expenses. The ITMIG database is a major resource for studying the characteristics, treatment strategies, and outcomes of patients with thymic malignancies. More than 2000 patients are enrolled. The database is open to all researches and has data transfer agreements with all major institutions.$75,000 spent · 29.5% of program spending
The 2024 Annual Meeting was held in Yokohama, Japan, in collaboration with the Japan Lung Cancer Society. The abstract book from the meeting is available in MEDIASTINUM.$55,672 spent · 21.9% of program spending
Where each dollar went · fiscal year 2025
Of every dollar it spent, 81¢ went to programs, 19¢ to management and 0¢ to fundraising.
Programs $254,492
Management $59,000
Fundraising $0
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
81%
Meets
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$216,569Fiscal year 2025
Expenses$313,492Fiscal year 2025
Total assets$215,219Fiscal year 2025
Total liabilities$0Fiscal year 2025
Fiscal year ending December2025
Revenue$216,569
Expenses$313,492
Net income−$96,923
Net assets$215,219
Notable sources of revenue
Percent of total revenue
Contributions
$216,569
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$215,219
Total liabilities
$0
Net assets
$215,219
Compensation
Not in our extract for this year.
Fiscal year ending December2024
Revenue$377,806
Expenses$229,580
Net income$148,226
Net assets$316,149
Notable sources of revenue
Percent of total revenue
Contributions
$377,806
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$316,149
Total liabilities
$0
Net assets
$316,149
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$164,486
Expenses$142,903
Net income$21,583
Net assets$167,923
Notable sources of revenue
Percent of total revenue
Contributions
$164,486
100.0%
Program services
—
—
Investment income
—
—
Other (net)
$0
0.0%
Assets / debt
Total assets
—
Total liabilities
—
Net assets
$167,923
Compensation
Not in our extract for this year.
Fiscal year ending December2022
Revenue$106,832
Expenses$95,369
Net income$11,463
Net assets$146,340
Notable sources of revenue
Percent of total revenue
Contributions
$106,832
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$146,340
Total liabilities
$0
Net assets
$146,340
Compensation
Not in our extract for this year.
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?